Drug Delivery and Glaucoma: Dextenza for Xen Patients

Show Description +

I. Paul Singh, MD, shares an example of one patient of a case series of 10 patients in which he has placed a Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) in the inferior and superior canaliculus for patients after Xen Gel Stent (Allergan) implantation.

Posted: 10/10/2022

Drug Delivery and Glaucoma: Dextenza for Xen Patients

I. Paul Singh, MD, shares an example of one patient of a case series of 10 patients in which he has placed a Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) in the inferior and superior canaliculus for patients after Xen Gel Stent (Allergan) implantation.

Posted: 10/10/2022

Please log in to leave a comment.

More in Glaucoma

Decreasing the Medication Burden With iDose TR

John P. Berdahl, MD; Natalia Morales, MD; and Justin Schweitzer, OD, FAAO

The Role of MIGS in Primary Angle-Closure Glaucoma

Arsham Sheybani, MD; I. Paul Singh, MD; and Ying Han, MD, PhD